FSD PHARMA Cash on Hand 2019-2023 | HUGE
FSD PHARMA cash on hand from 2019 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| FSD PHARMA Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $17 |
| 2021 | $35 |
| 2020 | $18 |
| 2019 | $6 |
| 2018 | $16 |
| FSD PHARMA Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-12-31 | $4 |
| 2023-09-30 | $4 |
| 2023-06-30 | $6 |
| 2023-03-31 | $9 |
| 2022-12-31 | $17 |
| 2022-09-30 | $24 |
| 2022-06-30 | $32 |
| 2022-03-31 | $29 |
| 2021-12-31 | $35 |
| 2021-09-30 | $39 |
| 2021-06-30 | $43 |
| 2021-03-31 | $50 |
| 2020-12-31 | $18 |
| 2020-09-30 | $14 |
| 2020-06-30 | $10 |
| 2020-03-31 | $6 |
| 2019-12-31 | $6 |
| 2019-09-30 | $5 |
| 2019-06-30 | $7 |
| 2019-03-31 | $13 |
| 2018-12-31 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.018B | $0.000B |
| FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.663B | 23.98 |
| Stryker (SYK) | United States | $124.585B | 30.89 |
| Medtronic (MDT) | Ireland | $105.150B | 14.89 |
| Boston Scientific (BSX) | United States | $98.912B | 32.89 |
| EssilorLuxottica (ESLOY) | France | $98.803B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.442B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.123B | 29.04 |
| ResMed (RMD) | United States | $26.124B | 26.12 |
| Terumo (TRUMY) | Japan | $24.607B | 34.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.518B | 15.78 |
| Baxter (BAX) | United States | $20.135B | 14.69 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.535B | 60.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.496B | 0.00 |
| Demant (WILYY) | Denmark | $9.782B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.014B | 23.88 |
| BellRing Brands (BRBR) | United States | $7.103B | 38.19 |
| Lantheus Holdings (LNTH) | United States | $4.273B | 11.03 |
| Haemonetics (HAE) | United States | $4.239B | 21.68 |
| Perrigo (PRGO) | Ireland | $4.057B | 11.60 |
| GN Store Nord (GNNDY) | Denmark | $3.581B | 23.19 |
| Envista Holdings (NVST) | United States | $3.394B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.394B | 16.05 |
| Green Thumb Industries (GTBIF) | United States | $2.720B | 86.20 |
| Neogen (NEOG) | United States | $2.584B | 24.85 |
| QuidelOrtho (QDEL) | United States | $2.559B | 9.29 |
| ICU Medical (ICUI) | United States | $2.361B | 17.62 |
| TG Therapeutics (TGTX) | United States | $2.160B | 699.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.913B | 0.00 |
| Owens & Minor (OMI) | United States | $1.843B | 17.69 |
| Verano Holdings (VRNOF) | United States | $1.841B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.654B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.466B | 45.66 |
| InMode (INMD) | Israel | $1.456B | 7.54 |
| LeMaitre Vascular (LMAT) | United States | $1.406B | 46.38 |
| AdaptHealth (AHCO) | United States | $1.244B | 9.36 |
| Warby Parker (WRBY) | United States | $1.169B | 0.00 |
| AtriCure (ATRC) | United States | $1.131B | 0.00 |
| MacroGenics (MGNX) | United States | $1.005B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.713B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.84 |
| Evolus (EOLS) | United States | $0.670B | 0.00 |
| Jin Medical (ZJYL) | China | $0.617B | 0.00 |
| Quanterix (QTRX) | United States | $0.604B | 0.00 |
| Valneva SE (VALN) | France | $0.565B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.528B | 11.44 |
| TerrAscend (TSNDF) | Canada | $0.507B | 0.00 |
| PetIQ (PETQ) | United States | $0.472B | 17.61 |
| ZimVie (ZIMV) | United States | $0.427B | 26.13 |
| Biote (BTMD) | United States | $0.405B | 3.86 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Surmodics (SRDX) | United States | $0.376B | 40.60 |
| Zynex (ZYXI) | United States | $0.368B | 42.41 |
| Aurora Cannabis (ACB) | Canada | $0.356B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.302B | 30.00 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.71 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 21.55 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.131B | 66.00 |
| InterCure (INCR) | Israel | $0.118B | 19.92 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.104B | 0.00 |
| Safety Shot (SHOT) | United States | $0.099B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.025B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.18 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |